Louis D. Saravolatz
YOU?
Author Swipe
View article: 305. Hospitalized Patients with Community-Acquired Pneumonia and Structural Lung Disease: A Multicenter Analysis
305. Hospitalized Patients with Community-Acquired Pneumonia and Structural Lung Disease: A Multicenter Analysis Open
Background Patients with structural lung disease (SLD) are more susceptible to community-acquired pneumonia (CAP) and are at higher risk for resistant organisms. CAP studies often exclude patients with SLD making it difficult to determine …
View article: P-708. Risk Factors Associated with Lower Respiratory Tract Infections in Adult Patients with Respiratory Syncytial Virus Infections
P-708. Risk Factors Associated with Lower Respiratory Tract Infections in Adult Patients with Respiratory Syncytial Virus Infections Open
Background Respiratory Syncytial Virus (RSV) is known to cause severe disease in elderly individuals and patients with underlying cardiopulmonary or immunocompromised conditions. Little is known about the factors associated with the lower …
View article: P-676. Risk Factors Associated with Longer Hospital Stay in Elderly Patients with Respiratory Syncytial Virus Infections
P-676. Risk Factors Associated with Longer Hospital Stay in Elderly Patients with Respiratory Syncytial Virus Infections Open
Background Annually, 3-7% of healthy older patients and 4-10% of high-risk adults develop respiratory syncytial virus (RSV) infections. Elderly patients above 65 years of age, with congestive heart failure, chronic lung disease, or weakene…
View article: Rhodomyrtone: a new anti-<i>Staphylococcus aureus</i> agent against resistant strains
Rhodomyrtone: a new anti-<i>Staphylococcus aureus</i> agent against resistant strains Open
Background Rhodomyrtone is a novel plant-derived antibiotic compound originally isolated from Rhodomyrtus tomentosa leaf extract. Objectives To evaluate the activity of rhodomyrtone against a group of MRSA strains, including isolates with …
View article: 511. Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment For COVID-19
511. Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment For COVID-19 Open
Background In December 2021, the FDA issued an emergency use authorization (EUA) for nirmatrelvir-ritonavir (Paxlovid). This was based on the randomized placebo-controlled trial data from the EPIC-HR study which showed that high-risk non-h…
View article: 2724. Community-acquired Pneumonia in Immunocompromised Patients: Predictors and Outcomes Associated with Empiric Broad-spectrum Antibiotic Treatment
2724. Community-acquired Pneumonia in Immunocompromised Patients: Predictors and Outcomes Associated with Empiric Broad-spectrum Antibiotic Treatment Open
Background Immunocompromised patients (ICP) are at higher risk of infection, but are often excluded from trials for community-acquired pneumonia (CAP). Due to limited data on CAP treatment in ICP, the IDSA/ATS CAP guideline omits recommend…
View article: Trends in Breast Cancer Incidence and Mortality in the United States From 2004-2018: A Surveillance, Epidemiology, and End Results (SEER)-Based Study
Trends in Breast Cancer Incidence and Mortality in the United States From 2004-2018: A Surveillance, Epidemiology, and End Results (SEER)-Based Study Open
The incidence and mortality data for patients with breast cancer in the United States are important to healthcare administrators for planning healthcare measures such as screening mammograms. In this study, we examined breast cancer incide…
View article: 1042. Inflammatory Representation of COVID-19 at the Time of Hospitalization: An Insight into the Mild, Moderate, Severe and Critical COVID-19 Disease
1042. Inflammatory Representation of COVID-19 at the Time of Hospitalization: An Insight into the Mild, Moderate, Severe and Critical COVID-19 Disease Open
Background The ongoing state of the COVID-19 pandemic necessitates the characterization of the biological basis of disease severity. We aimed to correlate the clinical severity of illness upon hospitalization with inflammatory sero-biomark…
View article: 1041. Association of SARS-CoV-2 Viral load in COVID-19 at the hospital representation
1041. Association of SARS-CoV-2 Viral load in COVID-19 at the hospital representation Open
Background The SARS-CoV-2 viral load and its association with COVID-19 severity remain a widely discussed topic with a little or no consensus. With these considerations we aimed to investigate SARS-CoV-2 viral load in the saliva/sputum in …
View article: 2066. Introduction of a Universal HIV Screening Electronic Health Record Alert at a Midwest Academic Health System
2066. Introduction of a Universal HIV Screening Electronic Health Record Alert at a Midwest Academic Health System Open
Background Universal human immunodeficiency virus (HIV) testing is recommended for patients ages 13-64 at least once by the Centers for Disease Control and Prevention. Screening lags behind these recommendations. Methods We performed an an…
View article: Incidence of bloodstream infections in patients with COVID-19: a retrospective cohort study of risk factors and outcomes
Incidence of bloodstream infections in patients with COVID-19: a retrospective cohort study of risk factors and outcomes Open
We found that male sex, abnormal chest X-ray, low SBP, and hypoalbuminemia upon hospital admission, admission to ICU, and having a procedure during hospitalization were independent predictors of BSIs in patients with COVID-19.
View article: Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral Drugs
Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral Drugs Open
At a crucial time with rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant globally, the United States Food and Drug Administration has issued an emergency use authorization for 2 oral antiviral…
View article: Six-Month Post-Acute COVID-19: High Self-Reported Morbidity Among Adults Younger Than Sixty Years and Females
Six-Month Post-Acute COVID-19: High Self-Reported Morbidity Among Adults Younger Than Sixty Years and Females Open
View article: Clinical and Immunological Assessment of Patients with Sars-Cov-2 Infections
Clinical and Immunological Assessment of Patients with Sars-Cov-2 Infections Open
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced coronavirus disease-2019 (COVID-19) has presented humanity with unprecedented challenges. Severe disease is associated with acute respiratory distress syndrom…
View article: 442. Sex-Related Differences in Mortality from COVID-19: Survival Analysis of Patients from an Urban Hospital
442. Sex-Related Differences in Mortality from COVID-19: Survival Analysis of Patients from an Urban Hospital Open
Background Mortality from COVID-19 is associated with male sex, older age, black race, and comorbidities including obesity. Our study identified risk factors for in-hospital mortality from COVID-19 using survival analysis at an urban cente…
View article: 314. Six-Month Post-Acute Sequelae of COVID-19: High Self-Reported Morbidity among Women and Younger Adults
314. Six-Month Post-Acute Sequelae of COVID-19: High Self-Reported Morbidity among Women and Younger Adults Open
Background Long term sequelae across multiple medical domains, including the respiratory, psychiatric, and neurocognitive have been reported after COVID-19. Studies evaluating the impact of this symptom burden, however, are lacking. We aim…
View article: 451. Is Antibody to Nucleocapsid More Prevalent in Individuals with Severe COVID-19?
451. Is Antibody to Nucleocapsid More Prevalent in Individuals with Severe COVID-19? Open
Background Virus-specific antibodies help to understand the prevalence of infections and the course of the immune response. Humans produce antibodies against the spike and nucleocapsid proteins of SARS-COV-2 virus. Patients with COVID-19 w…
View article: 36. Clinical Features of and Risk Factors for 30-day Readmission after an Initial Hospitalization with COVID-19
36. Clinical Features of and Risk Factors for 30-day Readmission after an Initial Hospitalization with COVID-19 Open
Background Little is known about risk factors for readmission after COVID-19 hospitalizations. Knowledge of these factors may help to identify patients at increased risk and may help to prevent these rehospitalizations. Methods This histor…
View article: Early Use of Remdesivir
Early Use of Remdesivir Open
At the time of the writing of this editorial, there have been over 600,000 deaths in the United States due to coronavirus disease 2019 (COVID-19), comparable to the number of deaths that occurred during the Spanish flu of 1918. In contrast…
View article: Incidence of Bloodstream Infections in Patients with COVID-19: A Retrospective Cohort Study of Risk Factors and Outcomes
Incidence of Bloodstream Infections in Patients with COVID-19: A Retrospective Cohort Study of Risk Factors and Outcomes Open
Objective : To describe the incidence, risk factors, and outcomes of bloodstream infections (BSIs) in patients with coronavirus disease 19 (COVID-19). Methods : This was a single-center retrospective cohort study of adults admitted for COV…
View article: A comparison of coronavirus disease 2019 (COVID-19) versus influenza during the pandemic: Can we distinguish COVID-19 from flu?
A comparison of coronavirus disease 2019 (COVID-19) versus influenza during the pandemic: Can we distinguish COVID-19 from flu? Open
We conducted a retrospective chart review examining the demographics, clinical history, physical findings, and comorbidities of patients with influenza and patients with coronavirus disease 2019 (COVID-19). Older patients, male patients, p…
View article: Predicting QT interval prolongation in patients diagnosed with the 2019 novel coronavirus infection
Predicting QT interval prolongation in patients diagnosed with the 2019 novel coronavirus infection Open
Introduction 2019 novel coronavirus (COVID‐19) patients frequently develop QT interval prolongation that predisposes them to Torsades de Pointes and sudden cardiac death. Continuous cardiac monitoring has been recommended for any COVID‐19 …
View article: Clinical Features and Risk Factors for In-Hospital Mortality From COVID-19 Infection at a Tertiary Care Medical Center, at the Onset of the US COVID-19 Pandemic
Clinical Features and Risk Factors for In-Hospital Mortality From COVID-19 Infection at a Tertiary Care Medical Center, at the Onset of the US COVID-19 Pandemic Open
Background: Mortality from COVID-19 has been associated with older age, black race, and comorbidities including obesity, Understanding the clinical risk factors and laboratory biomarkers associated with severe and fatal COVID-19 will allow…
View article: Clinical features and risk factors for community-onset bloodstream infections among coronavirus disease 2019 (COVID-19) patients
Clinical features and risk factors for community-onset bloodstream infections among coronavirus disease 2019 (COVID-19) patients Open
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the 'Save PDF' action button.
View article: Follicular B-Cell Lymphoma and Particulate Matter Associated with Environmental Exposure to Wood Dust
Follicular B-Cell Lymphoma and Particulate Matter Associated with Environmental Exposure to Wood Dust Open
BACKGROUND In humans, wood dust is a carcinogen. Indeed, a strong association between wood dust and lung cancer risk has been reported in woodworkers, as well as in the general population. CASE REPORT The patient was a 58-year-old man with…
View article: A case of Gemella morbillorum native valve endocarditis and results of in vitro susceptibility testing
A case of Gemella morbillorum native valve endocarditis and results of in vitro susceptibility testing Open
View article: Do risk factors at the time of hospital admission differ by sex for in-hospital mortality from coronavirus disease 2019 (COVID-19)?
Do risk factors at the time of hospital admission differ by sex for in-hospital mortality from coronavirus disease 2019 (COVID-19)? Open
Background: Sex-disaggregated data for coronavirus disease 2019 (COVID-19) reported higher hospitalized fatality rates among men than women. Objective: To determine whether the risk factors for in-hospital mortality from COVID-19, present …
View article: Predictors for in-hospital mortality from coronavirus disease 2019 (COVID-19) infection among adults aged 18–65 years
Predictors for in-hospital mortality from coronavirus disease 2019 (COVID-19) infection among adults aged 18–65 years Open
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the 'Save PDF' action button.
View article: Risk Factors for In-hospital Mortality from Coronavirus Disease 2019 Infection Among Black Patients—An Urban Center Experience
Risk Factors for In-hospital Mortality from Coronavirus Disease 2019 Infection Among Black Patients—An Urban Center Experience Open
Background Racial disparities are central in the national conversation about coronavirus disease 2019 (COVID-19) , with Black/African Americans being disproportionately affected. We assessed risk factors for death from COVID-19 among Black…
View article: Predictors for Severe COVID-19 Infection
Predictors for Severe COVID-19 Infection Open
Background COVID-19 is a pandemic disease caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Predictors for severe COVID-19 infection have not been well defined. Determination of risk factors for s…